Antipyrine clearance and metabolite formation: the influence of liver volume and smoking. 1986

P Spoelstra, and M W Teunissen, and A R Janssens, and B Weeda, and W van Duijn, and C W Koch, and D D Breimer

The influence of liver volume and cigarette smoking on antipyrine clearance and metabolite formation was studied in seventeen volunteers (eight smokers, nine non-smokers). Inter-test coefficient of variation of liver volume (as determined by ultrasound) was 6.3%. The mean antipyrine clearance was 49.3 +/- 18.3 ml min-1 and when normalized for liver volume 36.1 +/- 10.1 ml min-1 l-1. The antipyrine clearance per unit volume of liver was significantly higher in smokers (43.0 +/- 10.5 ml min-1 l-1), than in non-smokers (30.0 +/- 4.6 ml min-1 l-1) (P less than 0.01). No significant difference was found between the two groups as to the excreted amounts of 4-hydroxyantipyrine (OHA), norantipyrine (NORA), and 3-hydroxymethylantipyrine (HMA). Normalized for liver volume the mean clearances for production (Clm) of these metabolites were significantly higher in the group of smokers than in the group of non-smokers. The greatest change was observed for OHA formation. However, analysis of variance showed that the differences in the percentages of change of the mean Clm of these metabolites in the two groups are not significant.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077553 Edaravone An antipyrine derivative that functions as a free radical scavenger and neuroprotective agent. It is used in the treatment of AMYOTROPHIC LATERAL SCLEROSIS and STROKE. 1-Phenyl-3-methyl-5-pyrazolone,3-Methyl-1-phenyl-2-pyrazolin-5-one,Edarabone,MCI 186,MCI-186,Norantipyrine,Norphenazone,Phenylmethylpyrazolone,Radicava,1 Phenyl 3 methyl 5 pyrazolone,3 Methyl 1 phenyl 2 pyrazolin 5 one,MCI186
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Spoelstra, and M W Teunissen, and A R Janssens, and B Weeda, and W van Duijn, and C W Koch, and D D Breimer
April 1994, British journal of clinical pharmacology,
P Spoelstra, and M W Teunissen, and A R Janssens, and B Weeda, and W van Duijn, and C W Koch, and D D Breimer
January 1984, European journal of clinical pharmacology,
P Spoelstra, and M W Teunissen, and A R Janssens, and B Weeda, and W van Duijn, and C W Koch, and D D Breimer
May 1991, Xenobiotica; the fate of foreign compounds in biological systems,
P Spoelstra, and M W Teunissen, and A R Janssens, and B Weeda, and W van Duijn, and C W Koch, and D D Breimer
February 2001, Digestive diseases and sciences,
P Spoelstra, and M W Teunissen, and A R Janssens, and B Weeda, and W van Duijn, and C W Koch, and D D Breimer
November 1984, British journal of clinical pharmacology,
P Spoelstra, and M W Teunissen, and A R Janssens, and B Weeda, and W van Duijn, and C W Koch, and D D Breimer
December 1985, British journal of clinical pharmacology,
P Spoelstra, and M W Teunissen, and A R Janssens, and B Weeda, and W van Duijn, and C W Koch, and D D Breimer
January 1984, European journal of clinical pharmacology,
P Spoelstra, and M W Teunissen, and A R Janssens, and B Weeda, and W van Duijn, and C W Koch, and D D Breimer
September 1983, Research communications in chemical pathology and pharmacology,
P Spoelstra, and M W Teunissen, and A R Janssens, and B Weeda, and W van Duijn, and C W Koch, and D D Breimer
August 1982, Clinical pharmacology and therapeutics,
P Spoelstra, and M W Teunissen, and A R Janssens, and B Weeda, and W van Duijn, and C W Koch, and D D Breimer
January 1990, Minerva dietologica e gastroenterologica,
Copied contents to your clipboard!